---
title: "Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286281620.md"
description: "Galloway Capital Partners has acquired an 8.42% stake in WW International, asserting that the company is significantly undervalued despite its strong brand and growth in the wellness sector. Following a debt reduction from $1.4 billion to $460 million, WW's market cap has dropped below $100 million. Galloway highlights WW's 50% annual growth in its clinical business and valuable member data. Currently trading at 3.7x EBITDA, Galloway believes WW's true value is much higher and aims to work with the board to enhance shareholder value."
datetime: "2026-05-13T14:30:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286281620.md)
  - [en](https://longbridge.com/en/news/286281620.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286281620.md)
---

# Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price

NEW YORK--(BUSINESS WIRE)-- Galloway Capital Partners, LLC (“Galloway”), together with its affiliates, today announced that it has accumulated an ownership stake of approximately 8.42% in WW International, Inc. (“WW” or the “Company”).

Galloway believes WW is materially undervalued despite owning one of the world’s most recognized wellness brands and operating in the rapidly growing markets of weight management, metabolic health, GLP-1 support, and longevity.

Following its recent restructuring, WW reduced debt from approximately $1.4 billion to roughly $460 million while maintaining more than $220 million of cash on its balance sheet. Despite this improved capital structure, the Company’s market capitalization has fallen to less than $100 million.

“We believe the market is dramatically undervaluing WW’s brand, clinical business, member ecosystem, and long-term strategic potential,” said Bruce Galloway, Chief Investment Officer of Galloway Capital Partners.

Galloway noted that WW’s clinical business is growing more than 50% annually and believes the Company’s approximately 2.8 million members, combined with decades of proprietary consumer data, represent a highly valuable strategic asset in an increasingly personalized healthcare and wellness environment.

At current levels, WW trades at approximately 3.7x EBITDA, a substantial discount to peers in the digital health and wellness sector.

Galloway also stated that the Company has an opportunity to recruit a transformational CEO with expertise in consumer health, digital wellness, and subscription-based healthcare platforms.

“We believe WW is worth a multiple of its current trading value and look forward to engaging constructively with the Board and management team to help unlock shareholder value,” added Galloway.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260513227926/en/

Source: Galloway Capital Partners, LLC

### Related Stocks

- [WGHTQ.US](https://longbridge.com/en/quote/WGHTQ.US.md)
- [WW.US](https://longbridge.com/en/quote/WW.US.md)

## Related News & Research

- [Bruce Galloway Takes Activist Stake at WW International with 8.42% Stake](https://longbridge.com/en/news/286276602.md)
- [DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport](https://longbridge.com/en/news/286634042.md)
- [15:45 ET"Lean" Strengthens Saudi Arabia's Presence in Global Digital Health and Precision Medicine Ecosystems](https://longbridge.com/en/news/286811787.md)
- [NYC Health and Hospitals says hackers stole medical data and fingerprints during breach affecting at least 1.8 million people](https://longbridge.com/en/news/286799449.md)
- [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md)